• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Solution Center
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Solution Center
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Reducing the Risk of Comparator Sourcing

    Clinical Data Management

    Leveraging AI/ML Analytics for Better Clinical Development Decisions

    What is a Manufacturing Ecosystem and Why are They Growing?

    Get Smart: Integrating PAT Data into Existing Biotech Data Infrastructures
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    EUROAPI Invests €50M to Meet Growing Demand for Prostaglandins

    RK Pharma to Receive $200M Investment from PAG

    Axol Bioscience, StrataStem Partner on ‘Clinical Trial in a Dish’ for Alzheimer’s Disease

    TMC Expands Executive Team

    Peli BioThermal Opens Cold Chain Network Station in Southern California
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    EUROAPI Invests €50M to Meet Growing Demand for Prostaglandins

    RK Pharma to Receive $200M Investment from PAG

    Axol Bioscience, StrataStem Partner on ‘Clinical Trial in a Dish’ for Alzheimer’s Disease

    Peli BioThermal Opens Cold Chain Network Station in Southern California

    Purolite Expands Bioprocessing Production Capacity with New U.S. Facility
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Peli BioThermal Opens Cold Chain Network Station in Southern California

    Biocair Partners with TrakCel to Improve Visibility in the Supply Chain

    SpectronRx, RLS Partner to Boost Radiopharmaceutical Pipeline and Supply Chain

    Serialization and the War on Counterfeit Drugs

    Traceability & 2D Barcodes
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    RK Pharma to Receive $200M Investment from PAG

    Axol Bioscience, StrataStem Partner on ‘Clinical Trial in a Dish’ for Alzheimer’s Disease

    Almac Group Global Workforce Hits 7,000 Employees

    Amarna Therapeutics Names Henk Streefkerk CEO

    Trinity Life Sciences Names Leslie Orne CEO
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Regulatory Affairs: Accelerating Drug Development Timelines

    Berkshire Sterile Secures Over $230,000 in Training Grants

    Purification – A Bottleneck for Large-Scale Manufacturing of Oligonucleotide API?

    FDA 2023 Inspection Roadmap: Is “Readiness” in Your Annual Objectives?

    FDA Watch: Are You Suitably Staffed?
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    TaiMed Biologics

    Federal Equipment Company

    Quotient Sciences

    Almac Group

    Alcami
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    TaiMed Biologics

    Federal Equipment Company

    Quotient Sciences

    Almac Group

    Alcami
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Samsung Biologics to Participate in Frontier 1.5D Initiative

    Will develop a climate risk management model as part of 2050 Carbon Neutral Strategy in response to the challenges associated with climate change.

    Samsung Biologics to Participate in Frontier 1.5D Initiative
    Samsung Biologics joins Frontier 1.5D Project as part of 2050 Carbon Neutral Initiative.
    09.14.21
    Samsung Biologics, a contract development and manufacturing organization, has signed an MOU to participate in the Frontier 1.5D initiative to develop a climate risk management model as part of 2050 Carbon Neutral Strategy in response to the ongoing challenges associated with global climate change.
     
    The Frontier 1.5D project is a global collaborative effort to limit temperature rise to 1.5°C above pre-industrial levels, and local business leaders have joined forces with the British Embassy, Ewha Woman’s University and the Financial Supervisory Service, to collectively thrive for a net-zero future. Frontier 1.5D is expected to address uncertainties associated with climate change by analyzing the financial impact of climate change and climate response policies such as Greenhouse Gas (GHG) reductions.
     
    Samsung Biologics, as a business sector representative, will be closely monitoring, identifying, and providing data for each of its biopharmaceutical manufacturing plants through its Carbon Disclosure Project (CDP) initiative with Science Based Targets (SBT) to determine risks and opportunities on climate change as well as the financial impact to translate these data into actions.
     
    "We are proud and honored to be a part of the vital Frontier 1.5D initiative to ultimately redefine energy efficiency and reusable energy through the reduction of GHG emissions," said John Rim, CEO of Samsung Biologics. "Alongside our core mission to bring a healthier and sustainable future for humanity, Samsung Biologics will support the development of mid to long-term climate change strategies and action plans as part of our decarbonization efforts to achieve a net-zero future."
    Suggested For You
    Andelyn Biosciences, Odylia Therapeutics Partner to Manufacture Gene Therapy for Vision Loss Andelyn Biosciences, Odylia Therapeutics Partner to Manufacture Gene Therapy for Vision Loss
    Lonza Breaks Ground on Commercial Drug Product Facility in Stein Lonza Breaks Ground on Commercial Drug Product Facility in Stein
    EUROAPI Reports Progressive Restart of Prostaglandin Production EUROAPI Reports Progressive Restart of Prostaglandin Production
    Exothera Names Darren Leva as Chief Business Officer Exothera Names Darren Leva as Chief Business Officer
    New CDMO Vector BioMed Launches Operations New CDMO Vector BioMed Launches Operations
    Mikart Invests in New Liquids and Suspensions Suite Mikart Invests in New Liquids and Suspensions Suite
    Pfizer Revenues Soar to Record-Breaking $100B in 2022 Pfizer Revenues Soar to Record-Breaking $100B in 2022
    Lilly to Invest $450M at Manufacturing Site in Research Triangle Park Lilly to Invest $450M at Manufacturing Site in Research Triangle Park
    Sekisui Sekisui
    Samsung Biologics Samsung Biologics
    Lonza Further Invests in Drug Product Manufacturing Capabilities Lonza Further Invests in Drug Product Manufacturing Capabilities
    pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray
    Rentschler Biopharma to Support Albert Einstein Discovery Center Rentschler Biopharma to Support Albert Einstein Discovery Center
    First Patient is Dosed with Triumvira First Patient is Dosed with Triumvira's Investigational TAC-T Cell Adoptive Immunotherapy
    Recro Pharma Signs Renewable Energy Agreement with Georgia Power Recro Pharma Signs Renewable Energy Agreement with Georgia Power

    Related Breaking News

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
      Andelyn Biosciences, Odylia Therapeutics Partner to Manufacture Gene Therapy for Vision Loss

      Andelyn Biosciences, Odylia Therapeutics Partner to Manufacture Gene Therapy for Vision Loss

      Novel AAV capsid Anc80 enables efficient gene transfer.
      02.01.23

    • Breaking News | Facilities | Industry News
      Lonza Breaks Ground on Commercial Drug Product Facility in Stein

      Lonza Breaks Ground on Commercial Drug Product Facility in Stein

      Milestone for the development of Lonza’s first large-scale drug product manufacturing facility based in Stein.
      02.01.23

    • Breaking News | cGMP Manufacture | Industry News
      EUROAPI Reports Progressive Restart of Prostaglandin Production

      EUROAPI Reports Progressive Restart of Prostaglandin Production

      Majority of production at the Budapest site expected to be back online by mid-April 2023.
      02.01.23


    • Breaking News | Promotions & Moves
      Exothera Names Darren Leva as Chief Business Officer

      Exothera Names Darren Leva as Chief Business Officer

      Leva brings 20 years of broad commercial expertise to Exothera from a range of experiences with CDMOs, therapeutics, and software companies.
      02.01.23

    • Biologics, Proteins, Vaccines | Breaking News | Industry News
      New CDMO Vector BioMed Launches Operations

      New CDMO Vector BioMed Launches Operations

      The biomanufacturing company’s mission is to provide access to high-quality lentiviral vectors and address the vector supply bottleneck.
      02.01.23

    Loading, Please Wait..
    Trending
    • SpectronRx, RLS Partner To Boost Radiopharmaceutical Pipeline And Supply Chain
    • Samsung Biologics Accelerates Timeline Of New Fifth Plant
    • Biopharma Layoffs In 1Q23
    • Veeva Business Consulting Expands With New R&D Services
    • CRO Industry Trends & Challenges
    Breaking News
    • EUROAPI Invests €50M to Meet Growing Demand for Prostaglandins
    • RK Pharma to Receive $200M Investment from PAG
    • Axol Bioscience, StrataStem Partner on ‘Clinical Trial in a Dish’ for Alzheimer’s Disease
    • TMC Expands Executive Team
    • Peli BioThermal Opens Cold Chain Network Station in Southern California
    View Breaking News >
    CURRENT ISSUE

    May 2023

    • New Modalities Hog the Limelight
    • Cell and Gene Therapy is Coming of Age
    • Demand Surges for Cell and Gene Therapy Contract Manufacturing
    • Embracing a New Reality
    • Japan: A Unique Opportunity for Regenerative Medicines and Cell & Gene Therapies
    • Single-Use Technologies Enable Biologic Scaling
    • Get Smart: Integrating PAT Data into Existing Biotech Data Infrastructures
    • FTEs in Drug Discovery
    • Digital Transformation in Pharma
    • What is a Manufacturing Ecosystem and Why are They Growing?
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Sempera Organics and Alkemist Labs Announce Partnership for Mushroom Testing
    Nektium Expands International Distribution Network for Botanical Extracts
    Kemin Receives Positive EFSA Opinion for BetaVia Pure, its Beta-Glucan Ingredient
    Coatings World

    Latest Breaking News From Coatings World

    PPG’s New Paint for a New Start Initiative to Beautify Schools Worldwide with Colorful Makeovers
    Powder Technology, Inc. Announces New Electrical Coating
    Michelman Chosen as Inaugural Recipient of Innovation Research Interchange (IRI) Excellence Award
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Cue Health Nabs FDA's First De Novo Nod for an At-Home COVID Test
    ISO 13485:2016 Certification Granted to Boston BioProducts
    Paul Colvin Joins Ora Inc. as Chief Operating Officer
    Contract Pharma

    Latest Breaking News From Contract Pharma

    EUROAPI Invests €50M to Meet Growing Demand for Prostaglandins
    RK Pharma to Receive $200M Investment from PAG
    Axol Bioscience, StrataStem Partner on ‘Clinical Trial in a Dish’ for Alzheimer’s Disease
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Estée Lauder Announces Second Edition of Beauty&You Brand Incubator Program
    GetHarley Raises $52 Million in Latest Funding Round
    Refillable Skincare Products Face Hurdles Despite Growing Sustainability Awareness
    Happi

    Latest Breaking News From Happi

    Carrière Frères Introduces Candle Refills as New Sustainability Initiative
    Gen Z Entrepreneur Introduces The Ashley Marie Collection for 4C Hair Types
    The Estée Lauder Companies Expands Beauty&You Competition for Indian Beauty Brands
    Ink World

    Latest Breaking News From Ink World

    Siegwerk’s Center of Excellence in France Receives Facelift
    Epson announces MakeTheSwitch Campaign
    Pigments Market to Reach $26,598 Million by 2022: AMR
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Mark Andy reports successful Low Migration Workshop
    Ryback and Ryback Consulting launches Machinery division
    TLMI launches 2023 award programs
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    The Honest Company to Exit Europe, Asia
    TechnoPlants to Exhibit at ITMA
    Andritz Buys 100% Stake in Dan-Web
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Orthobiologics Market to Top $10.3 Billion by 2030
    Artelon Granted U.S. FDA 510(k) Clearance for FlexBand, FlexPatch & FlexBand Plus
    Synergy Spine Solutions Completes Enrollment in IDE Clinical Trial
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    ASSA ABLOY Receives Clearance from Mexico for HHI Acquisition
    Christoph Ostermann Named Chairman of Heliatek‘s Advisory Board
    Flexible and Printed Electronics Represented at productronica 2023

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login